Martin L Heubner

1PUBLICATIONS
11CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

|Nov 04, 2022
Optimal Treatment Duration of Bevacizumab as Front-Line Therapy for Advanced Ovarian Cancer: AGO-OVAR 17 BOOST/GINECO OV118/ENGOT Ov-15 Open-Label Randomized Phase III Trial.

Jacobus Pfisterer, Florence Joly, Gunnar Kristensen

Pageof 1

Frequent Collaborators

1 joint publications

Jacobus Pfisterer

1 joint publications

Florence Joly

1 joint publications

Gunnar Kristensen

1 joint publications

Ahmed El-Balat